Feb 22, 2024
Propanc Biopharma to Host Corporate Update Call Highlighting Recent Progress and Positive Results from Compassionate Use StudyManagement will provide insights on the remarkable results from the compassionate use study, the steps being undertaken to advance the Company’s lead asset, PRP, to a Phase 1b, First-in-Human (FIH), clinical study,…
View All Press Releases